Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are older than 2 years of age
- People who were previously diagnosed with a blood cancer or blood disorder (for the part of the study looking at past cases)
- People where doctors suspect a blood cancer or blood disorder and need to run tests using samples such as bone marrow, blood, lymph node tissue, fluid from around the spine, or fluid from around the lungs (for the part of the study looking at new cases)
- People where doctors suspect a blood cancer or blood disorder that has come back or stopped responding to treatment, and who need testing using bone marrow, blood, lymph node tissue, spinal fluid, or other tissue samples
- People where doctors suspect a long-term blood condition has progressed to a more serious stage, and who need testing using bone marrow, blood, lymph node tissue, spinal fluid, or other tissue samples
Who may not be able to join:
- People who are 2 years of age or younger
- People who do not have a confirmed or suspected diagnosis of a blood cancer or blood disorder
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 0521 702200
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Characterize multi-omics features of different hematological malignancies to identify disease biomarkers; Evaluate the anti-cancer activity of bioactive compounds and derivatives for functionally pharmacotyping the disease and build a nationally oriented multicenter DRP platform.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.